Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-07-18

Clinical Trial Update: A Study to Evaluate the Effectiveness of STELARA ™ (USTEKINUMAB) in the Treatment of Scalp Psoriasis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating Stelara (ustekinumab) for scalp psoriasis and plaque psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Stelara (ustekinumab)

Snippet

Sponsor: Paul Steven Yamauchi, MD, PhD | Conditions: Scalp Psoriasis, Plaque Psoriasis | Phase 4 | Status: UNKNOWN